Dr. William Raleigh Francis Jr., M.D. Preventive Medicine - Undersea and Hyperbaric Medicine Medicare: Accepting Medicare Assignments Practice Location: 9200 New Trails Dr, Suite 100, The Woodlands, TX 77381 Phone: 713-554-0645 Fax: 713-383-9376 |
Dr. Brian Bennett, MD, MPH Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 8600 Gosling Rd, The Woodlands, TX 77381 Phone: 281-719-7673 |
Dr. Julie Beth Yelin, MD Preventive Medicine - Public Health & General Preventive Medicine Medicare: Medicare Enrolled Practice Location: 1095 Evergreen Cir, Suite 200, The Woodlands, TX 77380 Phone: 832-380-9800 |
Dr. Conrad Ivan Dalton, MD Preventive Medicine - Aerospace Medicine Medicare: Not Enrolled in Medicare Practice Location: 98 S. Shawnee Ridge Circle, The Woodlands, TX 77382 Phone: 281-757-6081 Fax: 281-681-2772 |
News Archive
The Partnership for Research on Ebola Virus in Liberia, a U.S.-Liberia joint Clinical Research Partnership, today announced the opening of PREVAIL IV, a treatment trial for men who have survived Ebola virus disease (EVD) but continue to have evidence of Ebola virus genetic material, RNA, in their semen.
Reducing fossil fuel emissions steadily over coming years will prevent millions of premature deaths and help avoid the worst of climate change without causing the large spike in short-term warming that some studies have predicted, new analysis by researchers at Duke University and the University of Leeds finds.
AdvanSource Biomaterials Corporation, a leading developer, manufacturer and seller of advanced polymer technologies and materials for a broad range of medical devices, today announced that it has received a "Notice of Allowance" from the U.S. Patent and Trademark Office in connection with its antimicrobial patent application filed in June 2007. U.S. Patent No. 7,772,296, which is entitled "Antimicrobial Polyurethane Resins and Products Made Therefrom," covers a drug-free, antimicrobial technology to eradicate Methicillin-resistant Staphylococcus aureus ("MRSA") clinical infections associated with medical devices.
GW Pharmaceuticals plc a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today it has commenced a Phase 1b/2a clinical trial for the treatment of Recurrent Glioblastoma Multiforme.
ICAP Ocean Tomo, the intellectual property brokerage division of ICAP plc (IAP.L), is offering for sale a patent portfolio relating to a cardiothoracic surgery system owned by Medcanica, LLC. The portfolio consists of 14 U.S. issued patents, 4 non-U.S. patents, and 1 U.S. patent application.
› Verified 4 days ago